u/nl_verzekering

Where to look instead of asking, which will nearly always be faster.

The national shortage database is public, searchable and carries expected resolution dates. The subsidy criteria for each indication are published. Your pharmacist can check wholesaler availability in a few minutes, which is a different question from what is on the shelf.

Between those three, most questions on this board are answerable in half an hour with primary sources. The board is genuinely useful for experience, pricing comparison and the parts that are not written down anywhere — it is a poor substitute for a document that exists.

Disagree.

tove_ogunleye is right about cross-border recognition being narrower than the summaries suggest.

Cosigning on cross-border prescriptions.

This is the split the whole board depends on. Authorisation is European; payment is national.

read the combination arms separately from the monotherapy arms

a shortage in one member state is not a shortage in all of them

Nothing here is medical or legal advice, and eligibility questions have national answers that a pharmacist where you live can give you in minutes.

Yes — the shortage database is the source. The news coverage of it is downstream and usually a week behind.

reimbursement is national, not European, and that is the whole board

Rang three pharmacies for a private price and got three different numbers, all in the same city.

Gently disagree with the framing — nothing has gone wrong. Week 4 looking flat is the ordinary experience.

the shortage listing has an expected resolution date on it

the reimbursement criteria are published in most member states

Agreed — and normalising pack size before comparing prices is the fix for half these threads.

Left up. It names the member state and the pack size, which is all we ask of a pricing post.

Careful, personal importation provisions are narrow and specific and the general version circulating here is wrong.

Protein was the whole problem. Appetite dropped and I was eating well under target without noticing for a month.

Have the lifts held, dropped, or moved around?

the shortage listing has an expected resolution date on it

I confused two very similar words on my first order and asked here, expecting to be mocked. Three people explained it properly instead.

Combination and monotherapy arms must be read separately. Efficacy and tolerability both differ substantially between them and summaries routinely blur the two.

Agreed that appetite moves before the scale. Knowing that in advance saves a lot of week-three panic.

Do you have the publication or a summary of it?

Bought small deliberately because the evidence base is thin. That felt like the only defensible approach.

EU-wide advice is almost always wrong somewhere

Left up. It names the member state and the pack size, which is all we ask of a pricing post.

ask the dumb question, three other people are searching for it

the price you pay depends on the listing status of your indication

pens and vials are the same molecule with different logistics

Push back on the advice above: nobody here can tell a member what dose to take, however confidently it is phrased.

Do you have the publication or a summary of it?

Are you comparing against a GLP-1 monotherapy result? They are not comparable.

Read the combination paper twice before saying anything here. The monotherapy and combination arms tell genuinely different stories.

Combination and monotherapy arms must be read separately. Efficacy and tolerability both differ substantially between them and summaries routinely blur the two.

That result is preclinical. Worth flagging, since the thread has been reading it as human data.

Yes — importing US threads into an Australian question produces confident nonsense every single time.

Country added to the title — the answers differ across the union and the thread is unusable without it.

Agreed — and normalising pack size before comparing prices is the fix for half these threads.

week two with nothing happening is normal

Push back: the compounded arrangements changed and the advice you are quoting predates the change.

Country added to the title — the answers differ across the union and the thread is unusable without it.